Q3 2026 13F filing
Updated 10 days ago41 disclosed positions worth $485M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | C BRISTOL-MYERS SQUIBB CO | $38.2M | 613.0K | 7.89% | — |
| 2 | P PFIZER INC | $36.1M | 1.27M | 7.45% | — |
| 3 | M MEDTRONIC PLC | $32.9M | 381.2K | 6.78% | — |
| 4 | M MERCK & CO INC | $28.1M | 193.0K | 5.78% | — |
| 5 | I INCYTE CORP | $18.8M | 155.1K | 3.88% | — |
| 6 | B BIOMARIN PHARMACEUTICAL INC | $17.6M | 293.3K | 3.63% | — |
| 7 | C CVS HEALTH CORP | $16.8M | 196.6K | 3.47% | — |
| 8 | G GE HEALTHCARE TECHNOLOGIES I | $16.8M | 256.9K | 3.46% | — |
| 9 | E ELEVANCE HEALTH INC FORMERLY | $15.6M | 40.2K | 3.23% | — |
| 10 | B BIOGEN INC | $15.1M | 66.6K | 3.10% | — |
| 11 | I IONIS PHARMACEUTICALS INC | $14.7M | 330.0K | 3.04% | — |
| 12 | B BRUKER CORP | $14.1M | 217.4K | 2.90% | — |
| 13 | D DANAHER CORP DEL | $14M | 63.4K | 2.90% | — |
| 14 | A ABBOTT LABORATORIES | $14M | 141.7K | 2.89% | — |
| 15 | B BECTON DICKINSON & CO | $13.5M | 75.6K | 2.79% | — |
| 16 | B BOSTON SCIENTIFIC CORP | $13.4M | 308.1K | 2.77% | — |
| 17 | B BIO RAD LABS INC | $12.6M | 33.4K | 2.60% | — |
| 18 | Z ZIMMER BIOMET HOLDINGS INC | $11.7M | 131.5K | 2.41% | — |
| 19 | I IQVIA HLDGS INC | $11.4M | 42.3K | 2.34% | — |
| 20 | R REGENERON PHARMACEUTICALS | $10.8M | 14.2K | 2.22% | — |
| 21 | Q QIAGEN NV | $10.1M | 231.2K | 2.09% | — |
| 22 | L LABCORP HOLDINGS INC | $9.6M | 31.0K | 1.97% | — |
| 23 | A AVANTOR INC | $9.1M | 606.1K | 1.88% | — |
| 24 | C CARDINAL HEALTH INC | $9M | 40.3K | 1.85% | — |
| 25 | C CENTENE CORP DEL | $8.8M | 142.4K | 1.82% | — |
| 26 | U UNITEDHEALTH GROUP INC | $7.3M | 20.0K | 1.51% | — |
| 27 | A ASTRAZENECA PLC | $7.3M | 45.0K | 1.50% | — |
| 28 | ? N/A PTC THERAPEUTICS INC | $7.3M | 112.0K | 1.50% | — |
| 29 | J IOVANCE BIOTHERAPEUTICS INC | $5.8M | 388.5K | 1.19% | — |
| 30 | E EDWARDS LIFESCIENCES CORP | $5.2M | 60.4K | 1.08% | — |
| 31 | K KURA ONCOLOGY INC | $4.6M | 433.0K | 0.96% | — |
| 32 | S SYNDAX PHARMACEUTICALS INC | $4.5M | 241.7K | 0.94% | — |
| 33 | T TANDEM DIABETES CARE INC | $4.4M | 267.1K | 0.90% | — |
| 34 | H HCA HEALTHCARE INC | $4.3M | 10.0K | 0.88% | — |
| 35 | A ASCENDIS PHARMA A/S | $4.2M | 18.3K | 0.86% | — |
| 36 | T TRAVERE THERAPEUTICS INC | $4M | 68.0K | 0.83% | — |
| 37 | M MADRIGAL PHARMACEUTICALS INC | $3.3M | 6.5K | 0.68% | — |
| 38 | C CYTOKINETICS INC | $3M | 45.0K | 0.61% | — |
| 39 | D DENALI THERAPEUTICS INC | $2.8M | 137.7K | 0.59% | — |
| 40 | A ARDELYX INC | $2.3M | 686.8K | 0.48% | — |
| 41 | V VIRIDIAN THERAPEUTICS INC | $1.7M | 84.9K | 0.36% | — |